Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Infarction, Middle Cerebral Artery D020244 35 associated lipids
Optic Nerve Injuries D020221 4 associated lipids
Brain Hemorrhage, Traumatic D020201 1 associated lipids
Thrombophilia D019851 6 associated lipids
Hepatitis C, Chronic D019698 12 associated lipids
Hepatitis B, Chronic D019694 4 associated lipids
Neurodegenerative Diseases D019636 32 associated lipids
Capillary Leak Syndrome D019559 2 associated lipids
Endotoxemia D019446 27 associated lipids
Pancreatitis, Acute Necrotizing D019283 18 associated lipids
Postoperative Hemorrhage D019106 7 associated lipids
Leukostasis D018921 1 associated lipids
Encephalitis, Viral D018792 3 associated lipids
Pneumonia, Bacterial D018410 16 associated lipids
Leukocyte-Adhesion Deficiency Syndrome D018370 1 associated lipids
Respiratory Syncytial Virus Infections D018357 10 associated lipids
Carcinoma, Embryonal D018236 8 associated lipids
Pelvic Pain D017699 7 associated lipids
Soft Tissue Injuries D017695 2 associated lipids
Dermatitis, Allergic Contact D017449 20 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Tselepis AD et al. Electrocardiographic alterations induced by AGEPC in Wistar rats in relation to its hypotensive and hematologic effects. 1987 Comp. Biochem. Physiol. C, Comp. Pharmacol. Toxicol. pmid:2885139
Hayashi M et al. Characterization of the activity of a platelet activating factor antagonist, CV-3988. 1987 Jpn. J. Pharmacol. pmid:2888915
Bussolino F et al. Chick retina generates platelet-activating factor. 1987 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2890284
Mikashima H et al. An antagonistic activity of etizolam on platelet-activating factor (PAF). In vitro effects on platelet aggregation and PAF receptor binding. 1987 Jpn. J. Pharmacol. pmid:2890779
Gautheron PD et al. A study of PAF-induced ocular inflammation in the rat and its inhibition by the PAF antagonist, L-652,731. 1987 J. Pharm. Pharmacol. pmid:2891830
Kornecki E et al. Interactions of the alkyl-ether-phospholipid, platelet activating factor (PAF) with platelets, neural cells, and the psychotropic drugs triazolobenzodiazepines. 1987 Adv. Exp. Med. Biol. pmid:2893525
Patterson R et al. Evaluation of the effect of a platelet activating factor antagonist on platelet activating factor and Ascaris antigen-induced airway responses in rhesus monkeys. 1987 J. Lab. Clin. Med. pmid:3668360
Stewart AG and Piper PJ Actions of platelet-activating factor in the coronary circulation of the guinea pig in vitro. 1987 Prog. Clin. Biol. Res. pmid:3671383
Abstracts of the meeting: The role of platelet-activating factors in the immune response. Paris, France, June 25 and 26, 1987. 1987 Prostaglandins pmid:3671731
Bourgain RH et al. Arterial obstruction induced by PAF-acether (1-O-alkyl-sn-glycero-3-phosphocholine). 1987 Adv. Exp. Med. Biol. pmid:3673721
Myers AK and Bader TJ Role of adrenal steroids in the recovery from platelet activating factor challenge. 1987 Circ. Shock pmid:3677334
Homma H et al. Binding and internalization of platelet-activating factor 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine in washed rabbit platelets. 1987 J. Biol. Chem. pmid:3038889
Hsueh W et al. Platelet-activating factor: an endogenous mediator for bowel necrosis in endotoxemia. 1987 FASEB J. pmid:3678700
Myers A et al. Pharmacological manipulation of platelet-activating factor toxicity in rodents. 1987 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2960198
Hannun YA et al. Sphingosine inhibition of agonist-dependent secretion and activation of human platelets implies that protein kinase C is a necessary and common event of the signal transduction pathways. 1987 J. Biol. Chem. pmid:3115982
Martin TR et al. Relative contribution of leukotriene B4 to the neutrophil chemotactic activity produced by the resident human alveolar macrophage. 1987 J. Clin. Invest. pmid:2821074
Mangold HK et al. Biologically active lipids. Semi-synthesis of 3H-labeled ether glycerophospholipids and ether glyceroglycolipids from ratfish liver oil. 1987 FEBS Lett. pmid:3609315
Caffrey E et al. Aggregation responses to platelet-activating factor in normal subjects. 1987 Haemostasis pmid:3609916
Brunelleschi S et al. Platelet-activating factor-acether-induced relaxation of guinea pig airway muscle: role of prostaglandin E2 and the epithelium. 1987 J. Pharmacol. Exp. Ther. pmid:3478474
Bittman R et al. Synthesis and biochemical studies of analogs of platelet-activating factor bearing a methyl group at C2 of the glycerol backbone. 1987 J. Lipid Res. pmid:3611974
Terashita Z et al. CV-6209, a highly potent antagonist of platelet activating factor in vitro and in vivo. 1987 J. Pharmacol. Exp. Ther. pmid:3612533
Levy JV Spasmogenic effect of platelet activating factor (PAF) on isolated rat stomach fundus strip. 1987 Biochem. Biophys. Res. Commun. pmid:3619905
Huber M and Keppler D Inhibition of leukotriene D4 catabolism by D-penicillamine. 1987 Eur. J. Biochem. pmid:3622511
Ramesha CS and Pickett WC Fatty acid composition of diacyl, alkylacyl, and alkenylacyl phospholipids of control and arachidonate-depleted rat polymorphonuclear leukocytes. 1987 J. Lipid Res. pmid:3106551
Dallob A et al. Pharmacological evidence for a role of lipoxygenase products in platelet-activating factor (PAF)-induced hyperalgesia. 1987 Biochem. Pharmacol. pmid:2822047
Shimazaki N et al. Diketopiperazines as a new class of platelet-activating factor inhibitors. 1987 J. Med. Chem. pmid:3656347
Ruan CG et al. Studies on monoclonal antibodies against human platelets--a monoclonal antibody to human platelet glycoprotein I--SZ-2. 1987 Sci. Sin., Ser. B, Chem. Biol. Agric. Med. Earth Sci. pmid:3659897
Feuerstein G et al. Protective effect of a PAF-acether antagonist, BN 52021, in trichothecene toxicosis. 1987 Toxicol. Lett. pmid:3660430
Heinsohn C et al. The effect of bovine serum albumin on the synthesis of prostaglandin and incorporation of [3H]acetate into platelet-activating factor. 1987 Arch. Biochem. Biophys. pmid:3662526
Sperling RI et al. Effects of dietary supplementation with marine fish oil on leukocyte lipid mediator generation and function in rheumatoid arthritis. 1987 Arthritis Rheum. pmid:3663263
Siess W and Lapetina EG Phorbol esters sensitize platelets to activation by physiological agonists. 1987 Blood pmid:3663938
Coëffier E et al. Platelet-leukocyte interaction: activation of rabbit platelets by FMLP-stimulated neutrophils. 1987 Br. J. Pharmacol. pmid:3118996
Hirafuji M et al. Regulation of PAF-acether (platelet-activating factor) biosynthesis in cultured human vascular endothelial cells stimulated with thrombin. 1987 Biochim. Biophys. Acta pmid:2888488
Nakamura T et al. Platelet-activating factor in late asthmatic response. 1987 Int. Arch. Allergy Appl. Immunol. pmid:3804454
Ramesha CS and Pickett WC Species-specific variations in the molecular heterogeneity of the platelet-activating factor. 1987 J. Immunol. pmid:3100641
Bloom JW et al. Intravenous platelet activating factor does not affect lung epithelial permeability. 1987 Res. Commun. Chem. Pathol. Pharmacol. pmid:3326081
de Almeida PJ et al. [Biochemical bases of platelet activity in homeostasis and thrombogenesis. III]. 1987 Arq. Bras. Cardiol. pmid:3328601
O'Neill C Embryo-derived platelet activating factor: a preimplantation embryo mediator of maternal recognition of pregnancy. 1987 Domest. Anim. Endocrinol. pmid:3333935
Mathur RS et al. Current concepts in asthma. 1987 J Assoc Physicians India pmid:3320019
Whatley RE et al. Production of platelet-activating factor by endothelial cells. 1987 Semin. Thromb. Hemost. pmid:3321437
Kelton JG and Murphy WG Acute thrombocytopenia and thrombosis. Heparin-induced thrombocytopenia and thrombotic thrombocytopenic purpura. 1987 Ann. N. Y. Acad. Sci. pmid:3322132
Valone FH and Johnson B Modulation of platelet-activating-factor-induced calcium influx and intracellular calcium release in platelets by phorbol esters. 1987 Biochem. J. pmid:3322269
O'Flaherty JT and Nishihira J Arachidonate metabolites, platelet-activating factor, and the mobilization of protein kinase C in human polymorphonuclear neutrophils. 1987 J. Immunol. pmid:3029224
Henderson WR Lipid-derived and other chemical mediators of inflammation in the lung. 1987 J. Allergy Clin. Immunol. pmid:3031147
Chen DC [Phosphoinositide metabolism and platelet activation]. 1987 Sheng Li Ke Xue Jin Zhan pmid:2838899
Matsumoto T et al. G-protein dissociation, GTP-GDP exchange and GTPase activity in control and PMA treated neutrophils stimulated by fMet-Leu-Phe. 1987 Biochem. Biophys. Res. Commun. pmid:3032170
Kurachi M et al. Suppression of bronchial response to platelet activating factor following taurine administration. 1987 Adv. Exp. Med. Biol. pmid:3434419
Matsuno K et al. [Cytoplasm free calcium ions as a second messenger]. 1987 Rinsho Byori pmid:3437533
Kawamura Y et al. [A simple measurement of plasma platelet-activating factor (PAF) acetylhydrolase, normal level of activity, and distribution among lipoprotein fractions]. 1987 Rinsho Byori pmid:3437547
Kertscher HP and Ostermann G [Synthesis and platelet aggregating activity of structural analogs of platelet-activating factor with a heterocyclic head group]. 1987 Pharmazie pmid:3438334
Riedel A et al. The effect of the specific PAF antagonist BN 52021 and the calcium blocker diltiazem on PAF induced arrhythmogenicity. 1987 Pharmacol Res Commun pmid:3441484
Bussolino F et al. Intravascular release of platelet activating factor in children with sepsis. 1987 Thromb. Res. pmid:3441909
Hwang SB Specific receptor sites for platelet activating factor on rat liver plasma membranes. 1987 Arch. Biochem. Biophys. pmid:2821908
Chung KF et al. Effect of a ginkgolide mixture (BN 52063) in antagonising skin and platelet responses to platelet activating factor in man. 1987 Lancet pmid:2880069
Casals-Stenzel J and Weber KH Triazolodiazepines: dissociation of their Paf (platelet activating factor) antagonistic and CNS activity. 1987 Br. J. Pharmacol. pmid:2880622
Robaut C et al. PAF binding sites. Characterization by [3H]52770 RP, a pyrrolo[1,2-c]thiazole derivative, in rabbit platelets. 1987 Biochem. Pharmacol. pmid:2822048
Dale MM and Penfield A Comparison of the effects of indomethacin, RHC80267 and R59022 on superoxide production by 1,oleoyl-2,acetyl glycerol and A23187 in human neutrophils. 1987 Br. J. Pharmacol. pmid:2822195
Leff AR et al. Parasympathetic involvement in PAF-induced contraction in canine trachealis in vivo. 1987 J. Appl. Physiol. pmid:2881917
Spinks NR and O'Neill C Embryo-deprived platelet-activating factor is essential for establishment of pregnancy in the mouse. 1987 Lancet pmid:2432367
Livio M et al. A platelet-activating factor receptor antagonist protects against renal function deterioration in nephrotoxic nephritis. 1987 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2823570
Khandwala A et al. REV 2871 (CHBZ): a potent antiallergic agent with a novel mechanism of action. I. Activity profile as an inhibitor of mediator release. 1987 Biochem. Pharmacol. pmid:2435293
Stenzel H et al. Effect of the PAF-antagonist SRI 63-441 on the allergic reaction in awake dogs with natural asthma. 1987 Agents Actions Suppl. pmid:2823582
Alloatti G et al. Protective effect of verapamil on the cardiac and circulatory alterations induced by platelet-activating factor. 1987 J. Cardiovasc. Pharmacol. pmid:2435996
O'Flaherty JT and Wykle RL Metabolic origin and fate of platelet-activating factor. 1987 Agents Actions Suppl. pmid:2823583
Kappa JR et al. Carotid endarterectomy in patients with heparin-induced platelet activation: comparative efficacy of aspirin and iloprost (ZK36374). 1987 J. Vasc. Surg. pmid:2437338
Terashita Z et al. A lethal role of platelet activating factor in anaphylactic shock in mice. 1987 J. Pharmacol. Exp. Ther. pmid:3118009
de Arriba G et al. Changes in glomerular cross-sectional area induced by platelet activating factor. 1987 Nephrol. Dial. Transplant. pmid:3118261
Darius H and Lefer AM Pharmacologic antagonism of platelet activating factor and peptide leukotrienes inhibits guinea pig anaphylaxis. 1987 Prog. Clin. Biol. Res. pmid:3118384
Shalit M et al. Platelet-activating factor both stimulates and "primes" human polymorphonuclear leukocyte actin filament assembly. 1987 Blood pmid:3118991
Krishnamurthi S et al. Effect of phorbol 12-myristate 13-acetate (PMA) on agonist-induced arachidonate release and 5-hydroxytryptamine secretion in human platelets. Dependence of effects on agonist type and time of incubation with PMA. 1987 Biochim. Biophys. Acta pmid:3101746
Codde JP et al. Effects of altered prostanoid and lyso-PAF synthesis by marine oil diets on blood pressure of salt loaded spontaneously hypertensive rats. 1987 Agents Actions Suppl. pmid:3481207
Liu BN [Neoplastic membrane-toxic activity as one of the pathogenetic factors in blood cell and tumor growth changes]. 1987 Jan-Feb Patol Fiziol Eksp Ter pmid:3550649
Lurie A et al. Exercise- and allergen-induced asthma do not change the production of Paf-acether by neutrophils and platelets. 1987 Jul-Aug Bull Eur Physiopathol Respir pmid:3690021
Auriault C et al. The effector function of platelets is induced and regulated by T lymphocytes. 1987 Jul-Aug Ann. Inst. Pasteur Immunol. pmid:3118905
Fiedler VB et al. Comparison of cardiac and hemodynamic effects of platelet-activating factor-acether and leukotriene D4 in anesthetized dogs. 1987 Mar-Apr Basic Res. Cardiol. pmid:3606544
Arnoux B et al. Antigenic release of paf-acether and beta-glucuronidase from alveolar macrophages of asthmatics. 1987 Mar-Apr Bull Eur Physiopathol Respir pmid:3607326
Berdel WE et al. Lack of correlation between cytotoxicity of agonists and antagonists of platelet activating factor [paf-acether] in neoplastic cells and modulation of [3H]-paf-acether binding to platelets from humans in vitro. 1987 Nov-Dec Anticancer Res. pmid:3442414
Lakin KM et al. [Action of calcium antagonists on thrombocyte aggregation]. 1987 Sep-Oct Farmakol Toksikol pmid:2826225
Criscuoli M and Subissi A Catecholamines released from the adrenal medulla exert a compensatory, protective effect at beta 2-adrenoceptors against Paf-induced death in mice. 1988 Br. J. Pharmacol. pmid:2894872
Vivier E et al. Immunoregulatory functions of paf-acether. II. Decrease of CD2 and CD3 antigen expression. 1988 Eur. J. Immunol. pmid:2895712
Crouch MF and Lapetina EG No direct correlation between Ca2+ mobilization and dissociation of Gi during platelet phospholipase A2 activation. 1988 Biochem. Biophys. Res. Commun. pmid:3132162
Ferrell JE et al. Membrane bilayer balance and platelet shape: morphological and biochemical responses to amphipathic compounds. 1988 Biochim. Biophys. Acta pmid:3355815
There is a case for PAF-acether antagonists. Abstracts of the conference. Paris, France, May 25-27, 1988. 1988 Prostaglandins pmid:3399682
Valone FH Platelet-activating factor binding and metabolism during human platelet aggregation. 1988 Thromb. Res. pmid:3400077
O'Neill C et al. Embryo-derived platelet-activating factor. Its diagnostic and therapeutic future. 1988 Ann. N. Y. Acad. Sci. pmid:3195924
Nagpurkar A et al. Effect of rat phosphorylcholine-binding protein on platelet aggregation. 1988 Biochim. Biophys. Acta pmid:3167098
Wallace JL Release of platelet-activating factor (PAF) and accelerated healing induced by a PAF antagonist in an animal model of chronic colitis. 1988 Can. J. Physiol. Pharmacol. pmid:3167675
Benveniste J et al. Preformed PAF-acether and lyso PAF-acether are bound to blood lipoproteins. 1988 FEBS Lett. pmid:3338565
Barnes PJ et al. Platelet-activating factor as a mediator of allergic disease. 1988 J. Allergy Clin. Immunol. pmid:3286723
Nakayama R and Saito K [PAF and its physiological significance in normal tissue]. 1988 Seikagaku pmid:3286791
Valone FH Identification of platelet-activating factor receptors in P388D1 murine macrophages. 1988 J. Immunol. pmid:2832476
Prpic V et al. Biochemical and functional responses stimulated by platelet-activating factor in murine peritoneal macrophages. 1988 J. Cell Biol. pmid:2839520
Kroegel C The potential pathophysiological role of platelet-activating factor in human diseases. 1988 Klin. Wochenschr. pmid:2839728
Egger M et al. Human platelet electrorotation change induced by activation: inducer specificity and correlation to serotonin release. 1988 Biochim. Biophys. Acta pmid:3143424
Pitcock JA Morphometric studies of the renomedullary interstitial cells. 1988 Am. J. Med. Sci. pmid:3284348
Berstad A et al. Effect of platelet-activating factor and its receptor antagonist, SRI 63-675, on gastric bleeding in rats. 1988 Scand. J. Gastroenterol. pmid:3262915
Morley J et al. Pharmacological evaluation of prophylactic anti-asthma drugs by reference to the pathological sequelae of exposure to allergen or platelet activating factor. 1988 Agents Actions Suppl. pmid:3262989
Ng DS and Wong K Effect of sulfhydryl reagents on PAF binding to human neutrophils and platelets. 1988 Eur. J. Pharmacol. pmid:2846326
Ryan US et al. Influence of vasoactive agents on cytoplasmic free calcium in vascular endothelial cells. 1988 J. Appl. Physiol. pmid:3209566
Nogami M et al. [Effects of a platelet activating factor (PAF) antagonist CV-3988 on acute gastric erosions in rats by water immersion and restrained stress, and by ethanol]. 1988 Nihon Shokakibyo Gakkai Zasshi pmid:3210345